Form D Explorer

Form D — Kestrel Therapeutics Inc.

0001853373-25-000001 · filed 2025-02-21

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $16,000,000
Total sold: $8,000,000
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Kestrel Therapeutics Inc.
CIK: 1853373
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2020
Address: Attn Pagliuca Harvard Life Lab
Boston, MA 02134
Phone: 617-460-3772

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Frank G. Haluska · Executive Officer

Boston, MA Find on LinkedIn ↗
Denis Patrick · Director

Boston, MA Find on LinkedIn ↗
Omar Khalil · Director

Boston, MA Find on LinkedIn ↗
Andrew Phillips · Director

Boston, MA Find on LinkedIn ↗
Nicholas Saccomano · Director

Boston, MA Find on LinkedIn ↗
Barbara Sosnowski · Director

Boston, MA Find on LinkedIn ↗

View original on SEC EDGAR.